These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Are CD133 and CD271 useful in positive selection to enrich umbilical cord blood mesenchymal stem cells?]. Liu QH; Ge J; Liu KY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1286-91. PubMed ID: 21129278 [TBL] [Abstract][Full Text] [Related]
4. [Ex vivo expansion of megakaryocyte progenitor cells for CD133(+) cells derived from human umbilical cord blood]. Wang L; Chen DX; Fang N; Liu ZL; Zhang T; Wan WH; Qi Y; Liu JW Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):645-9. PubMed ID: 18549646 [TBL] [Abstract][Full Text] [Related]
5. Differentiation of human umbilical cord blood CD133+ stem cells towards myelo-monocytic lineage. Ruzicka K; Grskovic B; Pavlovic V; Qujeq D; Karimi A; Mueller MM Clin Chim Acta; 2004 May; 343(1-2):85-92. PubMed ID: 15115679 [TBL] [Abstract][Full Text] [Related]
6. Expression of transcription factor Oct-4 and other embryonic genes in CD133 positive cells from human umbilical cord blood. Baal N; Reisinger K; Jahr H; Bohle RM; Liang O; Münstedt K; Rao CV; Preissner KT; Zygmunt MT Thromb Haemost; 2004 Oct; 92(4):767-75. PubMed ID: 15467907 [TBL] [Abstract][Full Text] [Related]
7. Umbilical cord blood stem cells: induction of differentiation into mesenchymal lineages by cell-cell contacts with various mesenchymal cells. Park J; Setter V; Wixler V; Schneider H Tissue Eng Part A; 2009 Feb; 15(2):397-406. PubMed ID: 18759667 [TBL] [Abstract][Full Text] [Related]
8. [Changes of differentiation and gene expression of CD133+ cells in human umbilical cord blood induced by SCF and bFGF]. Zhang J; Zhu JS; Li QR; DU Y; Yang B; Li GX; Hu X Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):146-50. PubMed ID: 20137136 [TBL] [Abstract][Full Text] [Related]
9. Human cord blood CD133+ cells immunoselected by a clinical-grade apparatus differentiate in vitro into endothelial- and cardiomyocyte-like cells. Bonanno G; Mariotti A; Procoli A; Corallo M; Rutella S; Pessina G; Scambia G; Mancuso S; Pierelli L Transfusion; 2007 Feb; 47(2):280-9. PubMed ID: 17302775 [TBL] [Abstract][Full Text] [Related]
10. Both interleukin-3 and interleukin-6 are necessary for better ex vivo expansion of CD133+ cells from umbilical cord blood. Bordeaux-Rego P; Luzo A; Costa FF; Olalla Saad ST; Crosara-Alberto DP Stem Cells Dev; 2010 Mar; 19(3):413-22. PubMed ID: 19656071 [TBL] [Abstract][Full Text] [Related]
11. CD133(+) human umbilical cord blood stem cells enhance angiogenesis in experimental chronic hepatic fibrosis. Elkhafif N; El Baz H; Hammam O; Hassan S; Salah F; Mansour W; Mansy S; Yehia H; Zaki A; Magdy R APMIS; 2011 Jan; 119(1):66-75. PubMed ID: 21143528 [TBL] [Abstract][Full Text] [Related]
12. Effects of CXCR1 and CXCR2 inhibition on expansion and differentiation of umbilical cord blood CD133(+) cells into megakaryocyte progenitor cells. Adeli EK; Abolghasemi H; Ebtekar M; Pourpak Z; Kheirandish M Cytokine; 2011 Aug; 55(2):181-7. PubMed ID: 21555225 [TBL] [Abstract][Full Text] [Related]
13. A comparison of CFU-GM, BFU-E and endothelial progenitor cells using ex vivo expansion of selected cord blood CD133(+) and CD34(+) cells. Lu X; Baudouin SV; Gillespie JI; Anderson JJ; Dickinson AM Cytotherapy; 2007; 9(3):292-300. PubMed ID: 17464761 [TBL] [Abstract][Full Text] [Related]
14. Are purified or expanded cord blood-derived CD133+ cells better at improving cardiac function? Senegaglia AC; Barboza LA; Dallagiovanna B; Aita CA; Hansen P; Rebelatto CL; Aguiar AM; Miyague NI; Shigunov P; Barchiki F; Correa A; Olandoski M; Krieger MA; Brofman PR Exp Biol Med (Maywood); 2010 Jan; 235(1):119-29. PubMed ID: 20404026 [TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Tondreau T; Meuleman N; Delforge A; Dejeneffe M; Leroy R; Massy M; Mortier C; Bron D; Lagneaux L Stem Cells; 2005 Sep; 23(8):1105-12. PubMed ID: 15955825 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia improves expansion potential of human cord blood-derived hematopoietic stem cells and marrow repopulation efficiency. Roy S; Tripathy M; Mathur N; Jain A; Mukhopadhyay A Eur J Haematol; 2012 May; 88(5):396-405. PubMed ID: 22268587 [TBL] [Abstract][Full Text] [Related]
17. Oct-4A isoform is expressed in human cord blood-derived CD133 stem cells and differentiated progeny. Howe M; Zhao J; Bodenburg Y; McGuckin CP; Forraz N; Tilton RG; Urban RJ; Denner L Cell Prolif; 2009 Jun; 42(3):265-75. PubMed ID: 19438894 [TBL] [Abstract][Full Text] [Related]
18. WNT-conditioned media differentially affect the proliferation and differentiation of cord blood-derived CD133+ cells in vitro. Nikolova T; Wu M; Brumbarov K; Alt R; Opitz H; Boheler KR; Cross M; Wobus AM Differentiation; 2007 Feb; 75(2):100-11. PubMed ID: 17316380 [TBL] [Abstract][Full Text] [Related]
19. A new methodological sequence to expand and transdifferentiate human umbilical cord blood derived CD133+ cells into a cardiomyocyte-like phenotype. Cui YX; Kafienah W; Suleiman MS; Ascione R Stem Cell Rev Rep; 2013 Jun; 9(3):350-9. PubMed ID: 21948151 [TBL] [Abstract][Full Text] [Related]
20. Platelet growth factors suppress ex vivo expansion and enhance differentiation of umbilical cord blood CD133+ stem cells to megakaryocyte progenitor cells. Aghideh AN; Kheirandish M; Abolghasemi H; Gharehbaghian A Growth Factors; 2010 Dec; 28(6):409-16. PubMed ID: 20854188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]